2m 2m 2m 2m 2m 2m 2m
Gilead Sciences (GILD)
NASDAQ
$171.23+$1.50 (+0.88%)
Price as of Nov 12, 2026 8:20 AM EST- $210.5BMarket Cap
- 40.94%1-Year Change
- Drug Manufacturers - GeneralIndustry
Gilead Sciences (GILD)
$171.23+$1.50 (+0.88%)
GILD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $169.73 | ||
Change | -$1.14 (-0.67%) | ||
Open | $169.45 | ||
High | $170.48 | ||
Low | $168.37 | ||
Previous Close | $170.87 | ||
Volume | 4,883,553 | ||
30-Day Average Volume | 6,874,077 | ||
1-Week Change | -2.72% | ||
1-Month Change | 12.28% | ||
1-Year Change | 40.94% | ||
3-Year Change | 145.73% | ||
5-Year Change | 200.78% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $51.4B | ||
Market Cap | $210.5B | ||
Enterprise Value | $230.3B | ||
Period: QTR TTM FY | |||
Revenue | $8.3B | ||
Net Income | $2.4B | ||
Free Cash Flow | $4.8B | ||
EBIT | $3.1B | ||
EBITDA | $3.2B | ||
Net Working Capital | $4.6B | ||
EPS | $1.94 | ||
Enterprise Value/EBITDA | 72 | ||
Enterprise Value/Revenue | 28 | ||
P/B | 16 | ||
P/E | 87 | ||
PEG | 1 | ||
Price/Free Cash Flow | 44 | ||
Price/Operating Cash Flow | 42 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.93% | ||
Trailing Annual Dividend Yield | 1.91% | ||
Ex-Dividend Date | 12/15/2026 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 01/28/2013 | ||
Earnings & Revenue
Annual Dividend Yield